scholarly journals Prolyl Hydroxylase inhibitor repaired chemo-sensitivity through tumor blood vessel normalization in tumor mouse model

2018 ◽  
Vol WCP2018 (0) ◽  
pp. PO2-10-28
Author(s):  
Shinji Matsunaga ◽  
Shunji Nishide ◽  
Masayuki Shiota ◽  
Takehiro Yamaguchi ◽  
Shojiro Kitajima ◽  
...  
Keyword(s):  
Mouse Model ◽  
Blood Vessel ◽  
Prolyl Hydroxylase ◽  
Vessel Normalization ◽  
Tumor Blood Vessel ◽  
Tumor Mouse Model ◽  
Prolyl Hydroxylase Inhibitor

scholarly journals Tumour blood vessel normalisation by prolyl hydroxylase inhibitor repaired sensitivity to chemotherapy in a tumour mouse model

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Satoshi Koyama ◽  
Shinji Matsunaga ◽  
Masaki Imanishi ◽  
Yoichi Maekawa ◽  
Hiroya Kitano ◽  
...  
Keyword(s):  
Mouse Model ◽  
Blood Vessel ◽  
Prolyl Hydroxylase ◽  
Prolyl Hydroxylase Inhibitor ◽  
Tumour Blood

Tumor Blood Vessel “Normalization” Improves the Therapeutic Efficacy of Boron Neutron Capture Therapy (BNCT) in Experimental Oral Cancer

2012 ◽  
Vol 177 (1) ◽  
pp. 59-68 ◽  
Author(s):  
Ana J. Molinari ◽  
Emiliano C. C. Pozzi ◽  
Andrea Monti Hughes ◽  
Elisa M. Heber ◽  
Marcela A. Garabalino ◽  
...  
Keyword(s):  
Oral Cancer ◽  
Blood Vessel ◽  
Boron Neutron Capture Therapy ◽  
Neutron Capture ◽  
Therapeutic Efficacy ◽  
Neutron Capture Therapy ◽  
Vessel Normalization ◽  
Boron Neutron Capture ◽  
Tumor Blood Vessel

scholarly journals Effects of prolyl hydroxylase inhibitors on tumor blood vessels in tumor mouse model.

2021 ◽  
Vol 94 (0) ◽  
pp. 2-O-D1-2
Author(s):  
Shinji Matsunaga ◽  
Kazuyuki Yamaguchi ◽  
Kentaro Tokudome ◽  
Takehiro Yamaguchi ◽  
Shuhei Tomita
Keyword(s):  
Mouse Model ◽  
Blood Vessels ◽  
Prolyl Hydroxylase ◽  
Tumor Mouse Model ◽  
Tumor Blood Vessels

Menin is a tumor suppressor in bone -- a novel benign jaw tumor mouse model

2016 ◽  
Author(s):  
Sooyeon Lee ◽  
Peng Liu ◽  
Miriam Tschaffon ◽  
Alpaslan Tasdogan ◽  
Rainer Wittig ◽  
...  
Keyword(s):  
Tumor Suppressor ◽  
Mouse Model ◽  
Tumor Mouse Model

scholarly journals A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

2016 ◽  
Vol 67 (6) ◽  
pp. 861-871 ◽  
Author(s):  
Richard A. Brigandi ◽  
Brendan Johnson ◽  
Coreen Oei ◽  
Mark Westerman ◽  
Gordana Olbina ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Hypoxia Inducible Factor ◽  
Prolyl Hydroxylase ◽  
Prolyl Hydroxylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document